Phathom Pharmaceuticals Inc (PHAT) support and resistance · rev $132.6M
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
This page maps Phathom Pharmaceuticals Inc (PHAT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PHAT revenue for 2026-06-30 was $132.6M. Net income was -$48.0M. PHAT currently screens at market cap $622.7M.
PHAT currently screens at market cap $622.7M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PHAT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PHAT quote page for the session range and the stock page for the full model.
Not investment advice.